197 related articles for article (PubMed ID: 33017728)
21. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
22. [China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2023 Version)].
;
Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):1-9. PubMed ID: 36792074
[TBL] [Abstract][Full Text] [Related]
23. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
[TBL] [Abstract][Full Text] [Related]
24. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Lopes Pegna A; Picozzi G; Falaschi F; Carrozzi L; Falchini M; Carozzi FM; Pistelli F; Comin C; Deliperi A; Grazzini M; Innocenti F; Maddau C; Vella A; Vaggelli L; Paci E; Mascalchi M;
J Thorac Oncol; 2013 Jul; 8(7):866-75. PubMed ID: 23612465
[TBL] [Abstract][Full Text] [Related]
25. Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes.
Triphuridet N; Vidhyarkorn S; Worakitsitisatorn A; Sricharunrat T; Teerayathanakul N; Auewarakul C; Chungklay N; Krongthong W; Luengingkasoot S; Sornsamdang G; Patumanond J; Sritipsukho P
Lung Cancer; 2018 Aug; 122():243-248. PubMed ID: 30032839
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
27. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
[TBL] [Abstract][Full Text] [Related]
28. Adherence to annual lung cancer screening with low-dose CT scan in a diverse population.
Erkmen CP; Dako F; Moore R; Dass C; Weiner MG; Kaiser LR; Ma GX
Cancer Causes Control; 2021 Mar; 32(3):291-298. PubMed ID: 33394208
[TBL] [Abstract][Full Text] [Related]
29. Is low-dose computed tomography for lung cancer screening conveniently accessible in China? A spatial analysis based on cross-sectional survey.
Pan J; Wang J; Tao W; Wang C; Lin X; Wang X; Li R
BMC Cancer; 2024 Mar; 24(1):342. PubMed ID: 38486189
[TBL] [Abstract][Full Text] [Related]
30. Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting Lung Cancer as in Asian Male Ever-Smokers: A Systematic Review and Meta-Analysis.
Triphuridet N; Zhang SS; Nagasaka M; Gao Y; Zhao JJ; Syn NL; Hanaoka T; Ou SI; Shum E
J Thorac Oncol; 2023 Jun; 18(6):698-717. PubMed ID: 36775191
[TBL] [Abstract][Full Text] [Related]
31. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
32. Community-based lung cancer screening by low-dose computed tomography in China: First round results and a meta-analysis.
Li Y; Du Y; Huang Y; Zhao Y; Sidorenkov G; Vonder M; Cui X; Fan S; Dorrius MD; Vliegenthart R; Groen HJM; Liu S; Song F; Chen K; de Bock GH; Ye Z
Eur J Radiol; 2021 Nov; 144():109988. PubMed ID: 34695695
[TBL] [Abstract][Full Text] [Related]
33. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
Pinsky P; Gierada DS
Lung Cancer; 2020 Jan; 139():179-184. PubMed ID: 31812129
[TBL] [Abstract][Full Text] [Related]
34. Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study.
Wang L; Wang Y; Wang F; Gao Y; Fang Z; Gong W; Li H; Zhu C; Chen Y; Shi L; Du L; Li N
JMIR Public Health Surveill; 2023 Mar; 9():e43586. PubMed ID: 36917151
[TBL] [Abstract][Full Text] [Related]
35. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
[TBL] [Abstract][Full Text] [Related]
36. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
[TBL] [Abstract][Full Text] [Related]
37. Current lung cancer screening guidelines may miss high-risk population: a real-world study.
Ji G; Bao T; Li Z; Tang H; Liu D; Yang P; Li W; Huang Y
BMC Cancer; 2021 Jan; 21(1):50. PubMed ID: 33430831
[TBL] [Abstract][Full Text] [Related]
38. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
39. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
Meier-Schroers M; Homsi R; Gieseke J; Schild HH; Thomas D
Eur Radiol; 2019 Feb; 29(2):898-905. PubMed ID: 29992387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
